Aligos Therapeutics Inc. (ALGS)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
23.69
-0.25 (-1.06%)
At close: Jan 30, 2025, 3:59 PM
23.80
0.44%
After-hours Jan 30, 2025, 05:12 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Cash & Equivalents | 135.70M | 81.35M | 186.82M | 220.38M | 69.56M | 24.04M |
Short-Term Investments | n/a | 44.48M | 3.92M | 23.13M | 48.10M | 66.82M |
Long-Term Investments | n/a | n/a | 15.11M | n/a | 10.02M | n/a |
Other Long-Term Assets | 625.00K | -2.53M | 866.00K | -3.29M | 188.00K | 178.00K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 5.38M | 7.72M | 13.69M | 6.50M | 2.56M | 1.52M |
Total Current Assets | 141.08M | 133.54M | 204.42M | 250.02M | 120.23M | 92.37M |
Property-Plant & Equipment | 9.82M | 12.51M | 14.97M | 14.91M | 16.09M | 15.18M |
Goodwill & Intangibles | n/a | n/a | -3.77M | n/a | n/a | n/a |
Total Long-Term Assets | 10.44M | 13.15M | 30.95M | 15.29M | 26.29M | 15.36M |
Total Assets | 151.53M | 146.69M | 235.37M | 265.30M | 146.52M | 107.73M |
Account Payables | 2.52M | 4.74M | 3.02M | 3.31M | 3.77M | 2.98M |
Deferred Revenue | 1.31M | 9.21M | 7.64M | 7.89M | 6.85M | 3.18M |
Short-Term Debt | 10.38M | 6.29M | 5.81M | 5.01M | 2.45M | 1.25M |
Other Current Liabilities | 16.84M | 12.90M | 22.49M | 14.06M | 7.60M | 3.26M |
Total Current Liabilities | 23.91M | 33.13M | 38.96M | 30.27M | 13.82M | 7.49M |
Long-Term Debt | 7.90M | 9.43M | 11.55M | 10.50M | 11.88M | 12.61M |
Other Long-Term Liabilities | 27.64M | n/a | 133.00K | 379.00K | 185.71M | 101.38M |
Total Long-Term Liabilities | 35.54M | 9.66M | 11.68M | 14.99M | 197.59M | 113.99M |
Total Liabilities | 59.45M | 42.79M | 50.64M | 45.26M | 211.41M | 121.48M |
Total Debt | 11.14M | 12.57M | 14.46M | 13.01M | 14.33M | 13.86M |
Common Stock | 7.00K | 4.00K | 4.00K | 4.00K | 4.00K | 3.00K |
Retained Earnings | -486.80M | -399.12M | -303.07M | -174.74M | -66.20M | -13.93M |
Comprehensive Income | 545.00K | 401.00K | 452.00K | -188.00K | -115.00K | 3.00K |
Shareholders Equity | 92.08M | 103.90M | 184.73M | 220.04M | -64.89M | -13.75M |
Total Investments | -70.00K | 44.48M | 19.03M | 23.13M | 58.12M | 66.82M |